Human immunodeficiency virus-associated dementia - PubMed (original) (raw)

Review

Human immunodeficiency virus-associated dementia

J C McArthur et al. Semin Neurol. 1999.

Abstract

HIV-associated dementia will eventually develop in 15-20% of individuals with advanced HIV disease. It has become one of the leading causes of dementia in the young, with 10,000 new cases annually in the USA. The clinical syndrome includes progressive development of psychomotor slowing and memory impairment, eventually with brain atrophy and neurol loss. The pathology is characterized by infection of macrophages and microglia, marked activation of macrophages, and release of a variety of postinflammatory cytokines into the parenchyma. Antiretroviral therapy has impacted positively on the incidence rates, and at least partial reversal of neurologic deficits can be achieved in established dementias.

PubMed Disclaimer

Similar articles

• [Dementia and human inmmunodeficiency virus infection].
  Gray F. Gray F. Rev Neurol (Paris). 1998;154 Suppl 2:S91-8. Rev Neurol (Paris). 1998. PMID: 9834549 Review. French.
• The neuropathology of adult HIV infection.
  Bell JE. Bell JE. Rev Neurol (Paris). 1998 Dec;154(12):816-29. Rev Neurol (Paris). 1998. PMID: 9932303 Review.
• Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia.
  Glass JD, Fedor H, Wesselingh SL, McArthur JC. Glass JD, et al. Ann Neurol. 1995 Nov;38(5):755-62. doi: 10.1002/ana.410380510. Ann Neurol. 1995. PMID: 7486867
• Microglia in HIV-associated neurological diseases.
  Glass JD, Wesselingh SL. Glass JD, et al. Microsc Res Tech. 2001 Jul 15;54(2):95-105. doi: 10.1002/jemt.1124. Microsc Res Tech. 2001. PMID: 11455616 Review.
• The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
  Sacktor N. Sacktor N. J Neurovirol. 2002 Dec;8 Suppl 2:115-21. doi: 10.1080/13550280290101094. J Neurovirol. 2002. PMID: 12491162 Review.

Cited by

• An overview of AIDS dementia complex.
  Meehan RA, Brush JA. Meehan RA, et al. Am J Alzheimers Dis Other Demen. 2001 Jul-Aug;16(4):225-9. doi: 10.1177/153331750101600411. Am J Alzheimers Dis Other Demen. 2001. PMID: 11501344 Free PMC article.
• Neurologic aspects of HIV infection in infants and children: therapeutic approaches and outcome.
  Civitello L. Civitello L. Curr Neurol Neurosci Rep. 2003 Mar;3(2):120-8. doi: 10.1007/s11910-003-0063-4. Curr Neurol Neurosci Rep. 2003. PMID: 12583840 Review.
• HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes.
  Williams R, Yao H, Dhillon NK, Buch SJ. Williams R, et al. PLoS One. 2009 May 28;4(5):e5709. doi: 10.1371/journal.pone.0005709. PLoS One. 2009. PMID: 19479051 Free PMC article.
• Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment.
  Rozek W, Horning J, Anderson J, Ciborowski P. Rozek W, et al. Proteomics Clin Appl. 2008 Oct;2(10-11):1498-507. doi: 10.1002/prca.200780114. Epub 2008 Sep 10. Proteomics Clin Appl. 2008. PMID: 21136797 Free PMC article.
• IGF-IR in neuroprotection and brain tumors.
  Gualco E, Wang JY, Del Valle L, Urbanska K, Peruzzi F, Khalili K, Amini S, Reiss K. Gualco E, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(1):352-75. doi: 10.2741/3249. Front Biosci (Landmark Ed). 2009. PMID: 19273072 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Georg Thieme Verlag Stuttgart, New York
  • Ovid Technologies, Inc.